123 related articles for article (PubMed ID: 33665720)
21. The impact of primary tumor location on prognosis after colorectal lung metastasectomy.
Sponholz S; Oguzhan S; Mese M; Schirren M; Kirschbaum A; Schirren J
Int J Colorectal Dis; 2021 Aug; 36(8):1731-1737. PubMed ID: 33712904
[TBL] [Abstract][Full Text] [Related]
22. [Impact of primary tumor site on the prognosis in different stage colorectal cancer patients after radical resection].
Han J; Zhang X; Zhang AD; Zhou XL; Feng L; Wang JY; Wang GY
Zhonghua Wai Ke Za Zhi; 2018 Jan; 56(1):68-73. PubMed ID: 29325357
[No Abstract] [Full Text] [Related]
23. Tumor Sidedness, Recurrence, and Survival After Curative Resection of Localized Colon Cancer.
Malakorn S; Ouchi A; Hu CY; Sandhu L; Dasari A; You YN; Kopetz ES; Ellis LM; Chang GJ
Clin Colorectal Cancer; 2021 Mar; 20(1):e53-e60. PubMed ID: 33004292
[TBL] [Abstract][Full Text] [Related]
24. The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference.
Roberto M; Marchetti P; Arrivi G; Di Pietro FR; Cascinu S; Gelsomino F; Caputo F; Cerma K; Ghidini M; Ratti M; Pizzo C; Ficorella C; Parisi A; Cortellini A; Urbano F; Calandrella ML; Botticelli A; Dell'Aquila E; Minelli A; Fulgenzi C; Montori A; Pilozzi E; Mazzuca F
Int J Colorectal Dis; 2020 Aug; 35(8):1513-1527. PubMed ID: 32382835
[TBL] [Abstract][Full Text] [Related]
25. Yttrium-90 Hepatic Radioembolization for Advanced Chemorefractory Metastatic Colorectal Cancer: Survival Outcomes Based on Right- Versus Left-Sided Primary Tumor Location.
Wu V; Li MD; Goodwin JS; Wehrenberg-Klee EP; Zurkiya O; Kalva SP; Ganguli S
AJR Am J Roentgenol; 2021 Nov; 217(5):1141-1152. PubMed ID: 33594907
[No Abstract] [Full Text] [Related]
26. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
[TBL] [Abstract][Full Text] [Related]
27. Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
Taieb J; Kourie HR; Emile JF; Le Malicot K; Balogoun R; Tabernero J; Mini E; Folprecht G; Van Laethem JL; Mulot C; Bouché O; Aparicio T; Michel P; Thaler J; Bridgewater J; Van Cutsem E; Perkins G; Lepage C; Salazar R; Laurent-Puig P;
JAMA Oncol; 2018 Jul; 4(7):e173695. PubMed ID: 29167892
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological differences and correlations between right and left colon cancer.
Kalantzis I; Nonni A; Pavlakis K; Delicha EM; Miltiadou K; Kosmas C; Ziras N; Gkoumas K; Gakiopoulou H
World J Clin Cases; 2020 Apr; 8(8):1424-1443. PubMed ID: 32368535
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive genomic sequencing detects important genetic differences between right-sided and left-sided colorectal cancer.
Shimada Y; Kameyama H; Nagahashi M; Ichikawa H; Muneoka Y; Yagi R; Tajima Y; Okamura T; Nakano M; Sakata J; Kobayashi T; Nogami H; Maruyama S; Takii Y; Hayashida T; Takaishi H; Kitagawa Y; Oki E; Konishi T; Ishida F; Kudo SE; Ring JE; Protopopov A; Lyle S; Ling Y; Okuda S; Ishikawa T; Akazawa K; Takabe K; Wakai T
Oncotarget; 2017 Nov; 8(55):93567-93579. PubMed ID: 29212173
[TBL] [Abstract][Full Text] [Related]
30. Factors affecting prognosis in metastatic colorectal cancer patients.
Eker B; Ozaslan E; Karaca H; Berk V; Bozkurt O; Inanc M; Duran AO; Ozkan M
Asian Pac J Cancer Prev; 2015; 16(7):3015-21. PubMed ID: 25854399
[TBL] [Abstract][Full Text] [Related]
31. Histotype influences emergency presentation and prognosis in colon cancer surgery.
Sibio S; Di Giorgio A; D'Ugo S; Palmieri G; Cinelli L; Formica V; Sensi B; Bagaglini G; Di Carlo S; Bellato V; Sica GS
Langenbecks Arch Surg; 2019 Nov; 404(7):841-851. PubMed ID: 31760472
[TBL] [Abstract][Full Text] [Related]
32. [Correlation analysis between abundance of K-ras mutation in plasma free DNA and its correlation with clinical outcome and prognosis in patients with metastatic colorectal cancer].
Bai YQ; Liu XJ; Wang Y; Ge FJ; Zhao CH; Fu YL; Lin L; Xu JM
Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):666-71. PubMed ID: 24332053
[TBL] [Abstract][Full Text] [Related]
33. Impact of the Localization of the Primary Tumor and RAS/BRAF Mutational Status on Maintenance Strategies After First-line Oxaliplatin, Fluoropyrimidine, and Bevacizumab in Metastatic Colorectal Cancer: Results From the AIO 0207 Trial.
Noepel-Duennebacke S; Arnold D; Hertel J; Tannapfel A; Hinke A; Hegewisch-Becker S; Reinacher-Schick A
Clin Colorectal Cancer; 2018 Dec; 17(4):e733-e739. PubMed ID: 30145148
[TBL] [Abstract][Full Text] [Related]
34. Comparison of clinicopathological and survival features of right and left colon cancers.
Helvaci K; Eraslan E; Yildiz F; Tufan G; Demirci U; Berna Oksuzoglu O; Yalcintas Arslan U
J BUON; 2019; 24(5):1845-1851. PubMed ID: 31786846
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic and epidemiological characteristics of prognostic factors in post-surgical survival of colorectal cancer patients in Jiangsu Province, China.
Abasse Kassim S; Tang W; Abbas M; Wu S; Meng Q; Zhang C; Li X; Chen R
Cancer Epidemiol; 2019 Oct; 62():101565. PubMed ID: 31323459
[TBL] [Abstract][Full Text] [Related]
36. The Impact of Primary Tumor Location in Synchronous Metastatic Colorectal Cancer: Differences in Metastatic Sites and Survival.
Brouwer NPM; van der Kruijssen DEW; Hugen N; de Hingh IHJT; Nagtegaal ID; Verhoeven RHA; Koopman M; de Wilt JHW
Ann Surg Oncol; 2020 May; 27(5):1580-1588. PubMed ID: 31792717
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
Zlobec I; Bihl MP; Schwarb H; Terracciano L; Lugli A
Int J Cancer; 2010 Jul; 127(2):367-80. PubMed ID: 19908233
[TBL] [Abstract][Full Text] [Related]
38. The Significance of Sidedness in Patients with Metastatic Colorectal Cancer Treated with Triplet First-line Chemotherapy.
Bazarbashi S; Omar AT; Raddaoui L; Badran A; Alzahrani A; Aljubran A; Elhassan T
Asian Pac J Cancer Prev; 2019 Oct; 20(10):2891-2896. PubMed ID: 31653131
[TBL] [Abstract][Full Text] [Related]
39. Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series.
Negri F; De Giorgi A; Gilli A; Azzoni C; Bottarelli L; Gnetti L; Goldoni M; Manotti L; Sgargi P; Michiara M; Leonardi F; Rindi G; Cascinu S; Silini EM
Sci Rep; 2019 Mar; 9(1):3668. PubMed ID: 30842570
[TBL] [Abstract][Full Text] [Related]
40. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
Tabernero J; Lenz HJ; Siena S; Sobrero A; Falcone A; Ychou M; Humblet Y; Bouché O; Mineur L; Barone C; Adenis A; Yoshino T; Goldberg RM; Sargent DJ; Wagner A; Laurent D; Teufel M; Jeffers M; Grothey A; Van Cutsem E
Lancet Oncol; 2015 Aug; 16(8):937-48. PubMed ID: 26184520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
